Trial Profile
Impact of rituximab on cerebrospinal fluid cell gene expression in multiple sclerosis patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 11 Dec 2015 New trial record